Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 376.55 INR 0.7% Market Closed
Market Cap: 246.6B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Natco Pharma Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Natco Pharma Ltd
Interest Income Expense Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Natco Pharma Ltd
NSE:NATCOPHARM
Interest Income Expense
-â‚ą202m
CAGR 3-Years
-20%
CAGR 5-Years
3%
CAGR 10-Years
5%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Interest Income Expense
-â‚ą1.8B
CAGR 3-Years
-70%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Interest Income Expense
-â‚ą810.4m
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
5%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Interest Income Expense
â‚ą92m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Interest Income Expense
-â‚ą3B
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
-10%
M
Mankind Pharma Ltd
NSE:MANKIND
Interest Income Expense
â‚ą1.4B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Natco Pharma Ltd's Interest Income Expense?
Interest Income Expense
-202m INR

Based on the financial report for Jun 30, 2024, Natco Pharma Ltd's Interest Income Expense amounts to -202m INR.

What is Natco Pharma Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
5%

Over the last year, the Interest Income Expense growth was -39%. The average annual Interest Income Expense growth rates for Natco Pharma Ltd have been -20% over the past three years , 3% over the past five years , and 5% over the past ten years .

Back to Top